The 2023 british thoracic society guideline for pleural disease update on malignant pleural effusion

HIGHLIGHTS

• What: The authors provide a review of the 2023 BTS guidance in relation to effusions and specific points imaging and systemic anti-cancer treatment by concentrating a hypothetical patient vignette. This study reported a pleurodesis success rate of 100% in those treated with talc slurry (9/9) and 58% in those treated with pleural aspiration alone (4/7); however, this study did not reflect normal practice as patients in the ‘pleural aspiration` arm were post-thoracoscopy with a chest drain in situ for 72 h rather than more simple aspiration. Five studies reported on length of hospital . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.